BMA calls for ban on puberty blockers to be lifted

The British Medical Association (BMA) has called for the ban on puberty blockers for under-18s to be lifted and for a pause on the implementation of the Cass Review’s recommendations regarding gender care for children. The Cass Review, commissioned by NHS England, advocated a more holistic model with better mental health support rather than medical interventions like puberty blockers. Although widely welcomed, the BMA has expressed concerns about the review’s “unsubstantiated recommendations” and its impact on transgender healthcare. The BMA plans to evaluate the review and expects to finish by the end of the year, urging a pause in implementing the recommendations in the meantime. The Department of Health and Social Care, however, supports the review and its implementation by NHS England.

Do you think a pause on the implementation of the Cass Review’s recommendations is necessary to ensure the best care for transgender youth?

3 Likes

That’s a really complex issue. What do you think are the key factors that should be considered when evaluating the best approach to gender care for transgender youth?